Tempest Therapeutics's total assets for Q2 2024 were $42.17M, a decrease of -4.98% from the previous quarter. TPST total liabilities were $25.23M for the fiscal quarter, a 6.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.